Research analysts at StockNews.com started coverage on shares of China Pharma (NYSE:CPHI – Get Free Report) in a report issued on Wednesday. The brokerage set a “hold” rating on the stock.
China Pharma Price Performance
CPHI opened at $0.23 on Wednesday. China Pharma has a 52 week low of $0.17 and a 52 week high of $1.21. The business has a 50 day moving average price of $0.22 and a two-hundred day moving average price of $0.28. The company has a quick ratio of 0.24, a current ratio of 0.84 and a debt-to-equity ratio of 0.19.
China Pharma (NYSE:CPHI – Get Free Report) last released its earnings results on Wednesday, August 14th. The company reported ($0.09) earnings per share (EPS) for the quarter. China Pharma had a negative net margin of 70.47% and a negative return on equity of 60.19%. The company had revenue of $0.93 million during the quarter.
China Pharma Company Profile
China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.
Further Reading
- Five stocks we like better than China Pharma
- Insider Selling Explained: Can it Inform Your Investing Choices?
- 3 Leveraged ETFs to Multiply Returns
- How to Calculate Stock Profit
- A Tale of Two Titans: Unveiling the Value in Baidu and JD.com
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Is the AI-Capable iPhone 16 the Start of a Sales Super-Cycle?
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
